AGI Biopharmaceuticals' Private Equity Round

AGI Biopharmaceuticals raised a round of funding on November 28, 2011. Investors include Mentor Capital.

AGI Biopharmaceuticals is a European firm that has developed a patented, economic, melanoma vaccine with future multi-cancer application.…

Articles about AGI Biopharmaceuticals' Private Equity Round: